Moderna, in bid for transparency, discloses detailed plan of coronavirus vaccine trial

Moderna on Thursday took the unusual step of making public the detailed study plan for the company's large coronavirus vaccine trial, becoming the first developer in late-stage testing to do so amid calls for greater transparency by researchers and public health experts.